Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and a minimal header, replacing the expected study-record content. A Home link is shown for navigation.
    Difference
    19%
    Check dated 2026-09-23T01:06:33.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, reflecting a new build of the page. This change represents a backend or frontend update rather than content changes for the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:29:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page, indicating a small backend/software patch rather than a content change.
    Difference
    0.0%
    Check dated 2026-09-01T20:39:46.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A funding line noting the U.S. NIH Grant/Contract was added to the study record. This reflects government support for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T20:44:24.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a new document version. This update reflects versioning only and does not change the page content or functionality.
    Difference
    0.0%
    Check dated 2026-08-11T15:42:18.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Removed the Plain Language Summary from the Study Details page, eliminating the plain-language overview of the trial’s purpose and design.
    Difference
    0.0%
    Check dated 2026-08-04T09:19:40.000Z thumbnail image

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.